Unprecedented Growth Trajectory for Australia’s Health Industry - Burgess Rawson Director Geoff Sinclair
Australian medical and healthcare assets are emerging as the must-have investment asset class for 2024, fuelled by a compelling blend of factors and statistical trends says Burgess Rawson Director Geoff Sinclair.
